Silvia A. Marraco-Fuertes

Epalinges, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Shared acute phase traits in effector and memory human CD8 T cells.

Shared acute phase traits in effector and memory human CD8 T cells.

Journal: Current research in immunology

Published: July 13, 2021

Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses.

Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses.

Journal: Human vaccines & immunotherapeutics

Published: April 28, 2021

Early drop of circulating T cells negatively correlates with the protective immune response to Yellow Fever vaccination.

Early drop of circulating T cells negatively correlates with the protective immune response to Yellow Fever vaccination.

Journal: Human vaccines & immunotherapeutics

Published: April 30, 2020

Identification of a superagonist variant of the immunodominant Yellow fever virus epitope NS4b 214-222 by combinatorial peptide library screening.

Identification of a superagonist variant of the immunodominant Yellow fever virus epitope NS4b 214-222 by combinatorial peptide library screening.

Journal: Molecular immunology

Published: January 27, 2020

Analysis of cancer cell-intrinsic immune regulation in response to CD8+ T cell attack.

Analysis of cancer cell-intrinsic immune regulation in response to CD8+ T cell attack.

Journal: Methods in enzymology

Published: January 18, 2020

Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation.

Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation.

Journal: Immunity

Published: January 15, 2020

Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies.

Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies.

Journal: Vaccine

Published: October 08, 2019

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures.

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures.

Journal: Oncoimmunology

Published: June 24, 2019

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy.

Journal: Immunity

Published: June 11, 2018

T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.

T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.

Journal: European journal of immunology

Published: April 13, 2017

T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

Journal: Science translational medicine

Published: March 30, 2017

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

Journal: Frontiers in immunology

Published: October 16, 2016

Showing 1-12 of 26

Last Updated: 09/26/2026